drugset / Trial / NCT01759628
Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease
Phase 2
Completed
100 enrolled
Tehran University of Medical Sciences
Kashan University of Medical Sciences · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of study was to evaluate the effect of helicobacter pylori eradication on liver function tests, lipid profile, homeostasis model assessment-IR (HOMA-IR) index, and anthropometric measurements (body mass index and waist circumference)in subjects with non-alcoholic fatty liver disease.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Azithromycin | Small molecule | 500 mg | — |
| Subject | Omeprazole | Other / unclassified | 20 mg | — |
| Subject | bismuth subcitrate | Unknown | 240 mg | — |